Earnings
RUBY
19.27
+3.60%
0.67
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
91.17M
85.12M
--
--
--
--
0.00
--
--
--
5.22M
--
181.51M
94.40M
--
--
--
--
--
--
1.88M
96.28M
277.79M
--
5.48M
0.00
--
--
--
--
--
21.81M
--
--
--
554.00K
27.84M
74.94M
--
--
--
33.45M
108.39M
136.23M
81.00K
621.95M
-480.47M
--
--
--
141.56M
141.56M
277.79M
FY 2019-12-31
91.90M
191.39M
--
--
--
--
0.00
--
--
--
5.98M
0.00
289.27M
103.48M
--
--
--
--
--
--
2.09M
105.58M
394.84M
--
7.18M
0.00
--
--
--
--
--
26.26M
--
--
--
322.00K
33.76M
49.60M
--
--
--
37.27M
86.87M
120.63M
80.00K
586.80M
-312.74M
--
--
--
274.21M
274.21M
394.84M
FY 2018-12-31
307.06M
96.99M
--
--
--
--
0.00
--
--
--
9.74M
622.00K
414.41M
62.80M
--
--
--
--
--
--
1.90M
64.70M
479.11M
--
7.89M
0.00
--
--
--
--
--
5.63M
--
--
--
1.99M
20.00M
65.79M
--
--
--
309.00K
66.10M
86.10M
79.00K
543.04M
-150.08M
--
--
--
393.01M
393.01M
479.11M
FY 2017-12-31
104.29M
0.00
--
--
--
--
0.00
--
--
--
700.00K
0.00
104.99M
2.42M
--
--
--
--
--
--
284.00K
2.70M
107.69M
--
2.03M
0.00
--
--
--
--
--
2.79M
--
--
--
198.00K
7.16M
3.30M
--
--
--
1.12M
4.43M
11.58M
15.00K
17.28M
-60.98M
--
--
--
96.10M
-43.69M
107.69M
FY 2016-12-31
6.83M
0.00
--
--
--
--
0.00
--
--
--
53.00K
0.00
6.89M
868.00K
--
--
--
--
--
--
234.00K
1.10M
7.99M
--
1.18M
0.00
--
--
--
--
--
668.00K
--
--
--
71.00K
2.85M
2.99M
--
--
--
203.00K
3.19M
6.05M
8000.00
0.00
-17.13M
--
--
--
1.94M
1.94M
7.99M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out RUBY latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Rubius Therapeutics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.